Immuneering Corp (IMRX) earnings · $124.2M cap
These earnings events as JSON? API free 100/dayImmuneering Corp (IMRX) is a biotechnology company listed on US.
This IMRX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported IMRX revenue for 2023-12-31 was $0. Net income was -$53.5M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. IMRX currently screens at market cap $124.2M.
When the next IMRX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 100.0% from 2022-12-31 to 2023-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full IMRX research stays on the stock page; the tape stays on the quote page.
IMRX earnings FAQ
What is IMRX's latest net income?
Latest cached Immuneering Corp (IMRX) net income was -$53.5M. Statements: https://lician.com/financials/imrx
What is IMRX's latest diluted EPS?
Latest cached Immuneering Corp (IMRX) diluted EPS for Dec 31, 2023 was -$1.88.
What period does the latest IMRX earnings print cover?
The latest cached Immuneering Corp (IMRX) earnings print covers Dec 31, 2023. The prior cached period on this page is Dec 31, 2022.
Where are IMRX earnings listed?
Cached earnings facts for Immuneering Corp (IMRX) are listed at https://lician.com/earnings/imrx. Statements: https://lician.com/financials/imrx
Not investment advice.